# Istanbul Medeniyet University

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/istanbul-medeniyet-university/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 21.4 |
| Citations | 227,682 |
| City | Istanbul |
| Country | TR |
| Description | Istanbul Medeniyet University is a research organisation in Istanbul, TR. OpenAlex records 12,706 works and 227,682 citations for it. 3,276 researchers list it as their most recent affiliation. |
| Homepage | https://www.medeniyet.edu.tr |
| OpenAlex ID | https://openalex.org/I57913696 |
| Region | Istanbul |
| Researchers | 3,276 |
| ROR ID | https://ror.org/05j1qpr59 |
| Type | education |
| Works | 12,706 |

## University papers

Showing 12 of 45.

- [Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer](https://scholariq.org/papers/pembrolizumab-plus-chemotherapy-for-squamous-non-small-cell-lung-cancer/)
- [Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial](https://scholariq.org/papers/pembrolizumab-versus-chemotherapy-for-previously-untreated-pd-l1-expressing/)
- [Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study](https://scholariq.org/papers/prognostic-value-of-grip-strength-findings-from-the-prospective-urban-rural/)
- [The effect of physical activity on mortality and cardiovascular disease in 130 000 people from 17 high-income, middle-income, and low-income countries: the PURE study](https://scholariq.org/papers/the-effect-of-physical-activity-on-mortality-and-cardiovascular-disease-in-130/)
- [Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer](https://scholariq.org/papers/pembrolizumab-for-persistent-recurrent-or-metastatic-cervical-cancer/)
- [Cardiovascular Risk and Events in 17 Low-, Middle-, and High-Income Countries](https://scholariq.org/papers/cardiovascular-risk-and-events-in-17-low-middle-and-high-income-countries/)
- [Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey](https://scholariq.org/papers/use-of-secondary-prevention-drugs-for-cardiovascular-disease-in-the-community-in/)
- [Association of Urinary Sodium and Potassium Excretion with Blood Pressure](https://scholariq.org/papers/association-of-urinary-sodium-and-potassium-excretion-with-blood-pressure/)
- [Pembrolizumab Plus Chemotherapy in Squamous Non–Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Study](https://scholariq.org/papers/pembrolizumab-plus-chemotherapy-in-squamous-non-small-cell-lung-cancer-5-year/)
- [Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer](https://scholariq.org/papers/effect-of-first-line-serplulimab-vs-placebo-added-to-chemotherapy-on-survival-in/)
- [Association of dairy intake with cardiovascular disease and mortality in 21 countries from five continents (PURE): a prospective cohort study](https://scholariq.org/papers/association-of-dairy-intake-with-cardiovascular-disease-and-mortality-in-21/)
- [Amivantamab plus Chemotherapy in NSCLC with <i>EGFR</i> Exon 20 Insertions](https://scholariq.org/papers/amivantamab-plus-chemotherapy-in-nsclc-with-i-egfr-i-exon-20-insertions/)

## University researchers

- [Güler Öztürk](https://scholariq.org/researchers/guler-ozturk/)
- [Mahmut Bilal Doğan](https://scholariq.org/researchers/mahmut-bilal-dogan/)
- [Ahmet Müçteba Yıldırım](https://scholariq.org/researchers/ahmet-mucteba-y-ld-r-m/)

## University top topics

Showing 8 of 12.

- [Energy, Environment, Economic Growth](https://scholariq.org/topics/energy-environment-economic-growth/)
- [Market Dynamics and Volatility](https://scholariq.org/topics/market-dynamics-and-volatility/)
- [Education Practices and Challenges](https://scholariq.org/topics/education-practices-and-challenges/)
- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [COVID-19 and Mental Health](https://scholariq.org/topics/covid-19-and-mental-health/)
- [Kidney Stones and Urolithiasis Treatments](https://scholariq.org/topics/kidney-stones-and-urolithiasis-treatments/)
- [Magnetic Properties and Synthesis of Ferrites](https://scholariq.org/topics/magnetic-properties-and-synthesis-of-ferrites/)
- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.